Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 

[search the news]  
 

Health and Pharmaceutical News Archive

 
                                                                   

 
Search our news archive and pharma companies…

Today's News | Note: News feeds may no longer be available for the articles on this page.

Glaxo kidney cancer drug wins US panel support 6:20 PM 10/5/2009
Reuters
A US FDA advisory panel gave GlaxoSmithKline's experimental renal cell carcinoma drug Votrient (pazopanib) its full support. ...

Salix's late-stage pipeline may bring in suitors 2:25 PM 10/5/2009
Forbes
Expected regulatory approval for Salix Pharmaceuticals Ltd's drug Xifaxan in two new indications makes the company an attractive acquisition target for large pharma companies. ...

US panel narrowly backs new use for Schering drug 11:50 AM 10/5/2009
Reuters
Schering-Plough Corp narrowly won support from a US FDA advisory panel for its injectable drug PegIntron for melanoma patients undergoing surgery for the skin cancer. ...

Sequella secures funding for TB drug 11:40 AM 10/5/2009
Bizjournals.com
Sequella Inc won federal stimulus funds to pay for increased production of its lead tuberculosis drug SQ109 now in the first phase of clinical studies. ...

Astra, Bristol diabetes drug wins EU approval 10:50 AM 10/5/2009
Reuters
New diabetes drug Onglyza from AstraZeneca and Bristol-Myers Squibb has been approved for sale in Europe. They expect to launch Onglyza in Europe in the fourth quarter of 2009. ...

Seattle Genetics Ends Trial Of Cancer Drug 7:11 AM 10/5/2009
Wall Street Journal
Seattle Genetics Inc ended a midstage trial because its cancer drug dacetuzumab didn't look likely to meet the main goal. ...

Depomed says pain drug meets main goal of trial 6:56 AM 10/5/2009
Reuters
Depomed Inc said its experimental neuropathic pain drug DM-1796 met the main goal of reducing pain associated with postherpetic neuralgia (PHN). ...

Glaxo, XenoPort Pain Drug Meets Endpoints Of Midstage Trial 5:51 AM 10/5/2009
Wall Street Journal
GlaxoSmithKline and XenoPort Inc said the pain drug gabapentin enacarbil reached the primary goal of a midstage trial. ...

 

 

Sandoz Says Japan Needs More Generic-Drug Policies 5:11 AM 10/5/2009
Bloomberg
Novartis AG's generic-drug unit Sandoz will sell six more medicines in Japan this year and may buy compan ies. ...

Vaccine urged for pregnant women 5:27 AM 10/3/2009
Boston Herald
The vaccine protects the mother passing flu-fighting antibodies to the child. Newborns are vulnerable to the flu but can’t be vaccinated until they’re 6 months old. ...

Drug Maker Halts Test of Pancreatic Cancer Drug 4:47 AM 10/3/2009
New York Times
SciClone Pharmaceuticals discontinued a study of its experimental RP101 drug for pancreatic cancer. The decision to stop was based on a review of data by a safety monitoring group which did not explain its decision. ...

Allergan suing federal government over ban on off-label drug uses 11:22 AM 10/2/2009
Bizjournals.com
Allergan Inc filed a lawsuit against the federal government challenging rules preventing drug companies from educating doctors on alternative "off-label" drug use. ...

FDA gives Oncolytics Biotech green light for trial 10:02 AM 10/2/2009P
The Canadian Press
Oncolytics Biotech Inc said it has received approval to conduct a Phase 3 trial of a treatment for head and neck cancers using the company's Reolysin drug in combination with chemotherapy. ...

Cheap three-drug combination helps cut heart risks 5:03 PM 10/1/2009
Reuters
High-risk patients taking a combination of three older heart drugs cut their risk of a heart attack or stroke up to 80 percent. A generic statin, a generic blood pressure pill, and low-dose aspirin. ...

Catalyst shares rise on decision to continue with lead drug 10:19 AM 10/1/2009
Forbes
Catalyst Pharmaceutical Partners Inc will continue to develop its lead drug candidate CPP-109 for the treatment of cocaine and methamphetamine addiction. ...

Facet board recommends rejection of Biogen bid 9:50 AM 10/1/2009
Boston Globe
Facet Biotech Corp's board of directors unanimously recommended that stockholders reject the unsolicited conditional tender offer from Biogen Idec Inc. The companies have been jointly developing drugs for multiple sclerosis and cancer. ...

<- Day Earlier | Today's News


 

FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry

You may search any of the key words from this page using the search window at the top.

© 2012 Betterchem.com